Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial
- Resource Type
- Article
- Source
- The Lancet HIV; May 2022, Vol. 9 Issue: 5 pe332-e340, 9p
- Subject
- Language
- ISSN
- 24054704; 23523018